KOD
Kodiak Sciences Inc. Healthcare - Biotechnology Investor Relations →
Kodiak Sciences Inc. (KOD) closed at $43.96 as of 2026-05-01, trading 408.6% above its 200-week moving average of $8.64. The stock is currently moving closer to the line, down from 429.8% last week. With a 14-week RSI of 74, KOD is in overbought territory.
Over the past 14 weeks, up-weeks have carried more volume than down-weeks (2.29 buyers-vs-sellers ratio). When trading picks up, it's more often on days the price is rising — buyers are showing more interest than sellers.
Over the past 347 weeks of data, KOD has crossed below its 200-week moving average 1 time. On average, these episodes lasted 192 weeks. The average one-year return after crossing below was -86.3%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $2.7 billion, KOD is a mid-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -149.5%. The stock trades at 17.2x book value.
Share count has increased 18.0% over three years, indicating dilution.
Over the past 6.7 years, a hypothetical investment of $100 in KOD would have grown to $316, compared to $268 for the S&P 500. That represents an annualized return of 18.9% vs 15.9% for the index — confirming KOD as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
In the past 12 months, corporate insiders have made 1 open-market purchase totaling $60,000,008.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: KOD vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After KOD Crosses Below the Line?
Across 1 historical episodes, buying KOD when it crossed below its 200-week moving average produced an average return of -87.0% after 12 months (median -87.0%), compared to -8.0% for the S&P 500 over the same periods. After 24 months, the average return was -94.0% vs +11.0% for the index.
Each line shows $100 invested at the moment KOD crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
KOD has crossed below its 200-week MA 1 time with an average 1-year return of +-86.3% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Jan 2022 | Sep 2025 | 192 | 97.2% | -86.3% | -23.9% |
| Average | 192 | — | +-86.3% | — |
Frequently Asked Questions
Is KOD below its 200-week moving average?
No. Kodiak Sciences Inc. (KOD) is currently 408.6% above its 200-week moving average of $8.64. It would need to fall to $8.64 to cross below the line.
What is KOD's 200-week moving average price?
Kodiak Sciences Inc.'s 200-week moving average is $8.64 as of 2026-05-01. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when KOD drops below its 200-week moving average?
KOD has crossed below its 200-week moving average 1 time in our data. The average one-year return after these crossings was -86.3%, meaning the dips were not reliable buying signals for this particular stock. These episodes lasted 192 weeks on average.
Is KOD a good value right now?
Here's what our data says about KOD as of 2026-05-01: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 74 (overbought). Free cash flow is currently negative. Return on equity is -149.5%. Price-to-book is 17.2x. This is not a buy or sell recommendation — always do your own research.
How does KOD compare to the S&P 500?
Over the past 6.7 years, $100 invested in KOD would have grown to $316, compared to $268 for the S&P 500. That's 18.9% annualized vs 15.9% for the index. KOD has outperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-05-01